Electric skin patch offers drug-free solution to bacterial infections

Using a few zaps of electricity to the skin, researchers can stop bacterial infections without using any drugs. For the first time, researchers designed a skin patch that uses imperceptible electric currents to control microbes.

Lilly strikes deal with QurAlis for preclinical ALS candidate – Pharmaceutical Technology

Eli Lilly will pay QurAlis a $45m upfront payment for QRL-204, a preclinical ALS treatment. Credit: JHVEPhoto via Shutterstock. Eli Lilly is adding another asset

June 3, 2024

Allogeneic Stem Cell Therapy Falls Short on Stroke Outcomes

Bone marrow-derived allogeneic stem cell therapy shortly after ischemic stroke did not improve outcomes at 90 days, a phase II/III randomized clinical trial known as

January 18, 2024

Diseased protein degrader shows mixed results in breast cancer trial

An experimental drug developed by the biotech firm Arvinas and Pfizer — the first in a class of medicines based on a cell’s natural machinery

March 11, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.